Meet Our Team

James Jennings

James is a Bioinformatics Data Scientist and Inventor. He recieved his master’s degree in physics from the University of Houston-Clear Lake. While he was at UHCL, he developed a molecular dynamics model that incorporates quantum mechanical tunneling corrections into the free energy formula for the CRISPR/Cas9 system. He is the lead inventor and designer of the Markov Eklypse software, a next generation sequencing database that contains the sequencing data for all of the proteomic data within the proteomic database designed by AlphaFold. This database contains over 200 million proteins. The latest version of the Markov Eklypse prototype collects and cleans all the proteomic data from the protein databank.

Martin Deutsch

Martin holds a degree in Information Technology from Illinois State University and holds software certifications from multiple companies including Microsoft.  His previous experience as an an IT consultant has given him experience and expertise in many technologies.  This, along with owning three successful businesses will help support the development and marketing of the Markov Eklypse software.

Michael Butler

Michael is a graduate of the University of Saint Thomas, a prestigious Roman Catholic university in the heart of Houston, TX. He holds a BBA in Management Information Systems and has training with database management systems software. Michael is valuable to the development of the Markov Eklypse software in that he is well versed with business processes and knows what our business model and processes should look like. Michael also follows sound bioethical doctrine in how human and animal systems work on a deep, multi-faceted level. Michael’s degree of altruism shows that he is truly dedicated to his calling in helping people survive longer lives here on Earth, and his human relations skills prove that he has the drive to keep our company on track and profitable. Michael’s analytical skills in biological and chemical sciences have proven, with effective measures, that the Markov Eklypse AI module will enhance the capabilities of success in its efforts to promote event driven innovation of life forms through the transgenic structure of proteins that will be used to preserve, protect, and defend life with the goal of benefiting the common good of society.